본문 바로가기 대메뉴 바로가기

Introduction of Department

Department of Drug Discovery
The Department has played the role of an innovative translational research institution based on industry-university-research institute cooperation.

The Department is making efforts to become a world-class new drug research institution by developing innovative basic technologies and establishing a next-generation new drug pipeline of an international level.

Director
  • NameHwan Jung Lim
  • Office+82-42-860-7177
  • E-mailindium@krict.re.kr
Hwan Jung Lim

Major research fields

  • Development of new drug solution based on artificial intelligence and big data
  • Development of innovative drug based on precision medicine
  • Development of novel-concept disease treatment technology based on targeting chimera (TAC) technology
  • Establishment of efficacy/drugability evaluation platform for biological model-based disease treatment drugs
  • Research on development of rare disease targets and therapeutics

Major research accomplishments

  • Securing artificial intelligence-based toxicity/drugability prediction system and Drug Rescue technology based on the system​
  • Securing patient-derived big data analysis-based solution for innovative new drug target discovery, biomarker prediction, and verification​
  • Development of candidates of precision medicine-based anticancer agents against intractable cancers; technology transfer; and entry into clinical study​
  • Establishment of proteolytic agent (PROTAC and molecular glue) library and securing of leading materials​
  • Establishment of 3D biological model-based system for evaluating drug efficacy on brain diseases​
  • Discovery and verification of rare disease targets and development of therapeutics​